• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

Search Orphan Drug Designations and Approvals

  • Print
  • Share
  • E-mail
Generic Name:  Methotrexate with laurocapram
Date Designated:  10/15/1990
Orphan Designation:  Topical treatment of mycosis fungoides.
Orphan Designation Status:  Designated
FDA Orphan Approval Status:  Not FDA Approved for Orphan Indication
Echo Therapeutics, Ltd.
8 Penn Center
1628 JFK Blvd
Philadelphia, Pennsylvania 19103
United States

The sponsor address listed is the last reported by the sponsor to OOPD.
*Exclusivity Protected Indications are shown for approvals from Jan. 1, 2013, to the present.